Yeyi Zhu1, Sjurdur F Olsen2, Pauline Mendola1, Edwina H Yeung1, Allan Vaag3, Katherine Bowers1, Aiyi Liu1, Wei Bao1, Shanshan Li1, Camilla Madsen3, Louise G Grunnet3, Charlotta Granström2, Susanne Hansen2, Kelly Martin1, Jorge E Chavarro4, Frank B Hu4, Jens Langhoff-Roos5, Peter Damm6, Cuilin Zhang7. 1. From the Division of Intramural Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Rockville, MD; 2. Centre for Fetal Programming, Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark; 3. Department of Endocrinology and. 4. Departments of Nutrition and Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA; and. 5. Department of Obstetrics, Rigshospitalet University Hospital, Copenhagen, Denmark; 6. Center for Pregnant Women With Diabetes, Department of Obstetrics, Rigshospitalet, The Institute of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. 7. From the Division of Intramural Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Rockville, MD; zhangcu@mail.nih.gov.
Abstract
BACKGROUND: Given the long-term adverse sequelae of childhood obesity, identification of early life factors related to fetal growth and childhood obesity is warranted. Investigation on growth and obesity in early life in association with intrauterine exposure to maternal hyperglycemia, a common metabolic pregnancy complication, is of public health significance and clinical implications. OBJECTIVE: We investigated the association of fasting plasma glucose (FPG) concentrations during pregnancy with offspring growth and risk of overweight/obesity through age 7 y, after adjustment for confounders, including maternal prepregnancy obesity status. DESIGN: FPG concentrations at 28 gestational weeks (IQR: 22-32 wk) were extracted from medical records for 661 pregnancies complicated by gestational diabetes mellitus in the Danish National Birth Cohort (1996-2002). Offspring's ponderal index was derived from birth weight and length; age- and sex-specific body mass index (BMI) z scores at 5 mo, 12 mo, and 7 y were calculated based on WHO reference data. Relations between FPG and offspring growth and obesity were assessed by linear and Poisson regression with robust standard errors, adjusting for maternal prepregnancy BMI and sociodemographic and perinatal factors. RESULTS: At birth, maternal FPG during pregnancy was significantly associated with offspring ponderal index (β = 0.46; 95% CI: 0.14, 0.78 per 1-mmol/L increase) and risk of macrosomia (birth weight >4000 g) (RR = 1.21; 95% CI: 1.07, 1.38 per 1-mmol/L increase). At 7 y, higher maternal FPG concentrations were significantly associated with increased BMI z scores (β = 0.20; 95% CI: 0.04, 0.36) and elevated risk of overweight/obesity (RR = 1.21; 95% CI: 1.01, 1.50). Additional adjustment for birth weight and childhood lifestyle factors did not appreciably alter results. No associations were observed at 5 or 12 mo. CONCLUSION: Among women with gestational diabetes mellitus, maternal FPG concentrations during pregnancy were significantly and positively associated with offspring birth size and overweight/obesity risk at 7 y, adjusting for maternal prepregnancy BMI.
BACKGROUND: Given the long-term adverse sequelae of childhood obesity, identification of early life factors related to fetal growth and childhood obesity is warranted. Investigation on growth and obesity in early life in association with intrauterine exposure to maternal hyperglycemia, a common metabolic pregnancy complication, is of public health significance and clinical implications. OBJECTIVE: We investigated the association of fasting plasma glucose (FPG) concentrations during pregnancy with offspring growth and risk of overweight/obesity through age 7 y, after adjustment for confounders, including maternal prepregnancy obesity status. DESIGN: FPG concentrations at 28 gestational weeks (IQR: 22-32 wk) were extracted from medical records for 661 pregnancies complicated by gestational diabetes mellitus in the Danish National Birth Cohort (1996-2002). Offspring's ponderal index was derived from birth weight and length; age- and sex-specific body mass index (BMI) z scores at 5 mo, 12 mo, and 7 y were calculated based on WHO reference data. Relations between FPG and offspring growth and obesity were assessed by linear and Poisson regression with robust standard errors, adjusting for maternal prepregnancy BMI and sociodemographic and perinatal factors. RESULTS: At birth, maternal FPG during pregnancy was significantly associated with offspring ponderal index (β = 0.46; 95% CI: 0.14, 0.78 per 1-mmol/L increase) and risk of macrosomia (birth weight >4000 g) (RR = 1.21; 95% CI: 1.07, 1.38 per 1-mmol/L increase). At 7 y, higher maternal FPG concentrations were significantly associated with increased BMI z scores (β = 0.20; 95% CI: 0.04, 0.36) and elevated risk of overweight/obesity (RR = 1.21; 95% CI: 1.01, 1.50). Additional adjustment for birth weight and childhood lifestyle factors did not appreciably alter results. No associations were observed at 5 or 12 mo. CONCLUSION: Among women with gestational diabetes mellitus, maternal FPG concentrations during pregnancy were significantly and positively associated with offspring birth size and overweight/obesity risk at 7 y, adjusting for maternal prepregnancy BMI.
Authors: David J Pettitt; Sonia McKenna; Ciara McLaughlin; Christopher C Patterson; David R Hadden; David R McCance Journal: Diabetes Care Date: 2010-03-09 Impact factor: 17.152
Authors: Samantha F Ehrlich; Lisa G Rosas; Assiamira Ferrara; Janet C King; Barbara Abrams; Kim G Harley; Monique M Hedderson; Brenda Eskenazi Journal: Am J Epidemiol Date: 2013-03-15 Impact factor: 4.897
Authors: Danielle R Stevens; Brian Neelon; James R Roberts; Sarah N Taylor; Roger B Newman; John E Vena; Kelly J Hunt Journal: J Dev Orig Health Dis Date: 2020-02-20 Impact factor: 2.401
Authors: Wei Perng; Brandy M Ringham; Deborah H Glueck; Katherine A Sauder; Anne P Starling; Mandy B Belfort; Dana Dabelea Journal: Am J Clin Nutr Date: 2017-06-28 Impact factor: 7.045
Authors: Ming Ding; Jorge Chavarro; Sjurdur Olsen; Yuan Lin; Sylvia H Ley; Wei Bao; Shristi Rawal; Louise G Grunnet; Anne Cathrine B Thuesen; James L Mills; Edwina Yeung; Stefanie N Hinkle; Wei Zhang; Allan Vaag; Aiyi Liu; Frank B Hu; Cuilin Zhang Journal: Diabetologia Date: 2018-06-12 Impact factor: 10.122
Authors: Yeyi Zhu; Sjurdur F Olsen; Pauline Mendola; Thorhallur I Halldorsson; Edwina H Yeung; Charlotta Granström; Anne A Bjerregaard; Jing Wu; Shristi Rawal; Jorge E Chavarro; Frank B Hu; Cuilin Zhang Journal: Am J Clin Nutr Date: 2017-06-07 Impact factor: 7.045
Authors: Shaoning Jiang; April M Teague; Jeanie B Tryggestad; Christopher E Aston; Timothy Lyons; Steven D Chernausek Journal: Placenta Date: 2017-06-06 Impact factor: 3.481